|
Coronary heart disease
|
0.160 |
Biomarker
|
disease |
BEFREE |
HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
|
27169356 |
2017 |
|
Coronary heart disease
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease.
|
27417586 |
2016 |
|
Coronary heart disease
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Relatively low numbers of kringle 4 type 2 repeats in apolipoprotein(a) and specific haplotypes of the SLC22A3-LPAL2-LPA region on chromosome 6 are associated with an increased risk of coronary disease.
|
23278389 |
2013 |
|
Coronary heart disease
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Lack of association between four SNPs in the SLC22A3-LPAL2-LPA gene cluster and coronary artery disease in a Chinese Han population: a case control study.
|
23036009 |
2012 |
|
Coronary heart disease
|
0.160 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.
|
19198611 |
2009 |
|
Coronary heart disease
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.
|
19198611 |
2009 |
|
Coronary heart disease
|
0.160 |
Biomarker
|
disease |
BEFREE |
Children of parents with CHD differed from controls in total cholesterol and apolipoprotein A II concentrations.
|
1929512 |
1991 |
|
Coronary Artery Disease
|
0.150 |
GeneticVariation
|
disease |
GWASCAT |
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease.
|
29212778 |
2018 |
|
Coronary Artery Disease
|
0.150 |
Biomarker
|
disease |
BEFREE |
HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
|
27169356 |
2017 |
|
Coronary Artery Disease
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
One single nucleotide polymorphism, rs3088442, in the SLC22A3-LPAL2-LPA gene cluster was significantly associated with both plasma Lp(a) levels and CAD severity.
|
27417586 |
2016 |
|
Coronary Artery Disease
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Relatively low numbers of kringle 4 type 2 repeats in apolipoprotein(a) and specific haplotypes of the SLC22A3-LPAL2-LPA region on chromosome 6 are associated with an increased risk of coronary disease.
|
23278389 |
2013 |
|
Coronary Artery Disease
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
We for the first time explored the association of the four SNPs in the SLC22A3-LPAL2-LPA gene cluster with CAD in a large Chinese Han sample.
|
23036009 |
2012 |
|
Coronary Artery Disease
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.
|
19198611 |
2009 |
|
Coronary Artery Disease
|
0.150 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.
|
19198611 |
2009 |
|
Arteriosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The important role of apolipoprotein A-II in ezetimibe driven reduction of high cholesterol diet-induced atherosclerosis.
|
30500605 |
2019 |
|
Atherosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The important role of apolipoprotein A-II in ezetimibe driven reduction of high cholesterol diet-induced atherosclerosis.
|
30500605 |
2019 |
|
Lipoprotein (a) measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms.
|
28512139 |
2017 |
|
Lipoprotein (a) measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study.
|
26377243 |
2015 |
|
Arteriosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.
|
23241412 |
2013 |
|
Atherosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.
|
23241412 |
2013 |
|
Triglycerides measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
|
Arteriosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Apolipoprotein A-II (APOA2) plays an ambiguous role in lipid metabolism, obesity, and atherosclerosis.
|
17446329 |
2007 |
|
Atherosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Apolipoprotein A-II (APOA2) plays an ambiguous role in lipid metabolism, obesity, and atherosclerosis.
|
17446329 |
2007 |
|
Arteriosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Apolipoprotein A-II, HDL metabolism and atherosclerosis.
|
12119188 |
2002 |
|
Atherosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Apolipoprotein A-II, HDL metabolism and atherosclerosis.
|
12119188 |
2002 |